Nomura Holdings’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-3,104
Closed -$450K 1781
2024
Q1
$450K Sell
3,104
-1,470
-32% -$124K ﹤0.01% 1278
2023
Q4
$421K Buy
+4,574
New +$465K ﹤0.01% 1396
2023
Q1
Sell
-5,593
Closed -$324K 1481
2022
Q4
$324K Hold
5,593
﹤0.01% 1037
2022
Q3
$527K Buy
5,593
+3,700
+195% +$527K ﹤0.01% 1097
2022
Q2
$429K Buy
+1,893
New +$634K ﹤0.01% 1152
2022
Q1
Sell
-3,208
Closed -$2.15M 2014
2021
Q4
$2.15M Buy
+3,208
New +$2.45M 0.01% 979
2021
Q2
Sell
-5,475
Closed -$6.01M 2046
2021
Q1
$6.01M Buy
+5,475
New +$7.23M 0.01% 493

Other funds holding CDLX

Nomura Holdings's CDLX Position: Q2 2024 in Review

Nomura Holdings sold out of Cardlytics (CDLX) in Q2 2024, closing a stake of 3,104 shares — an estimated $450K sold.

Nomura Holdings first reported a position in CDLX in Q1 2021 and held it in 7 quarters. The position peaked at $6.01M in Q1 2021. 127 funds tracked by Wall St. Rank hold CDLX as of Q2 2024.

  • Nomura Holdings reported no remaining Cardlytics position as of Q2 2024 after selling out during the quarter.
  • Nomura Holdings sold 3,104 Cardlytics shares in Q2 2024, an estimated $450K.
  • Nomura Holdings first reported a position in Cardlytics in Q1 2021 and held it in 7 quarters.
  • Nomura Holdings's Cardlytics position peaked at $6.01M in Q1 2021.
  • 127 funds tracked by Wall St. Rank held Cardlytics as of Q2 2024.

Based on Nomura Holdings's 13F filing for Q2 2024, filed 14 Aug 2024.